- Home
- Clinical Resources Search
- PQI: Glofitamab-gxbm (COLUMVI®) for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
Glofitamab-gxbm (COLUMVI®) for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
Download PQI pdf 0.27MB
Last Updated: December 19, 2024
By: Matthew Lei, PharmD, BCOP | J. Erika Haydu, MD, PhD
About this PQI
The purpose of this PQI is to review clinical considerations around the use of glofitamab-gxbm in the treatment of relapsed or refractory diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS) or large B-cell lymphoma (LBCL) arising from follicular lymphoma.
How to Use a Positive Quality Intervention (PQI)
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.
Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQIFind Similar Resources
All Resources
PQI
PQI
PQI
PQI
PQI: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)
Last Updated: 10/14/2025
PQI: Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia
Last Updated: 09/19/2025
PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC
Last Updated: 07/07/2025
PQI: Revumenib (Revuforj) for the Management of Acute Leukemia
Last Updated: 06/20/2025
PQI in Action
PQI in Action
PQI in Action
PQI in Action
PQI in Action: Epcoritamab (Epkinly®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Last Updated: 10/09/2025
PQI in Action: Nirogacestat (OGSIVEO®) use in Management of Adults with Progressing Desmoid Tumors (or fibromatosis or aggressive fibromatosis)
Last Updated: 10/04/2025
PQI in Action: Abiraterone acetate (Yonsa®) Patient Selection and Management
Last Updated: 09/10/2025
PQI in Action: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma
Last Updated: 09/10/2025
PQI Podcast
PQI Podcast
PQI Podcast
PQI Podcast
S9 E8: Mental Strength at Work
Last Updated: 10/23/2025
S9 E7: A Haven of Healing
Last Updated: 10/09/2025
S9 E6: Healing Through Sound: A Breast Cancer Journey
Last Updated: 09/25/2025
S9 E5: Global Health, Cancer Survivorship, and Advancing Equity
Last Updated: 09/25/2025
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit: Elranatamab
Last Updated: 08/25/2025
Treatment Support Kit: Mirdametinib
Last Updated: 06/10/2025
Treatment Support Kit: Abemaciclib
Last Updated: 04/11/2025
Treatment Support Kit: Temozolomide
Last Updated: 01/01/2025
Video
Video
Video
Video
Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide
Last Updated: 10/28/2025
Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications
Last Updated: 10/28/2025
Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)
Last Updated: 10/28/2025
Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma
Last Updated: 10/28/2025
Patient Education Sheet
Patient Education Sheet
PQI in Action
Patient Education Sheet
Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Last Updated: 10/22/2025
Rituximab and Hyaluronidase
Last Updated: 10/14/2025
PQI in Action: Epcoritamab (Epkinly®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Last Updated: 10/09/2025
Etoposide
Last Updated: 10/07/2025
Patient Education Sheet
Immunotherapy
Glofitamab
Last Updated: 08/16/2025
Up Close with Glofitamab
Last Updated: 05/16/2025
Patient Education Sheet
Immunotherapy
Glofitamab
Last Updated: 08/16/2025
Up Close with Glofitamab
Last Updated: 05/16/2025
Patient Education Sheet
PQI
PQI in Action
Gilteritinib
Last Updated: 04/02/2024
PQI: Gilteritinib (Xospata®) for Relapsed/Refractory Acute Myeloid Leukemia
Last Updated: 10/02/2023
PQI in Action: Putting Gilteritinib (Xospata®) for Relapsed/Refractory Acute Myeloid Leukemia (AML) into Action
Last Updated: 04/01/2022
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Last Updated: 10/22/2025
Rituximab
Last Updated: 10/14/2025
Rituximab and Hyaluronidase
Last Updated: 10/14/2025
Tislelizumab and FOLFOX
Last Updated: 09/24/2025



